Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate

Л. И. Карпенко(State Research Center of Virology and Biotechnology VECTOR), A. A. Ilyichev(State Research Center of Virology and Biotechnology VECTOR), S. V. Sharabrin(State Research Center of Virology and Biotechnology VECTOR), Sergei I. Bazhan(State Research Center of Virology and Biotechnology VECTOR), Л. А. Орлова(State Research Center of Virology and Biotechnology VECTOR), М. Ш. Азаев(State Research Center of Virology and Biotechnology VECTOR), Д. Н. Щербаков(State Research Center of Virology and Biotechnology VECTOR), M. B. Borgoyakova(State Research Center of Virology and Biotechnology VECTOR), Б. Н. Зайцев(State Research Center of Virology and Biotechnology VECTOR), Oleg V. Pyankov(State Research Center of Virology and Biotechnology VECTOR), А. П. Рудометов(State Research Center of Virology and Biotechnology VECTOR), Ekaterina A. Volosnikova(State Research Center of Virology and Biotechnology VECTOR), I. A. Pyshnaya(Institute of Chemical Biology and Fundamental Medicine), Надежда Б. Рудометова(State Research Center of Virology and Biotechnology VECTOR), Н В Волкова(State Research Center of Virology and Biotechnology VECTOR), Anna V. Zaykovskaya(State Research Center of Virology and Biotechnology VECTOR)
Vaccines
January 21, 2021
Cited by 39


Related Papers